United StatesBreaking News

President Donald Trump said the US will begin guiding some neutral ships trapped in the Persian Gulf out through the Strait of Hormuz starting Monday. Bloomberg's Tony Czuczka has the latest.

Pinterest (NYSE:PINS) reported financial results for the first quarter ended March 31, 2026, characterized by steady top-line expansion and record engagement levels.

Palantir Technologies (NASDAQ:PLTR) reported explosive financial results for the first quarter of 2026, solidifying its position as a primary beneficiary of the global shift toward integrated artificial intelligence and data analytics.

OSI Systems (NASDAQ:OSIS) reported record-breaking financial results for the third quarter of fiscal 2026, underscored by significant growth in its security and healthcare divisions.

Genco Shipping & Trading (NYSE: GNK) confirmed that Diana Shipping (NYSE:DSX) has launched a conditional, unsolicited tender offer to acquire all outstanding Genco shares.

Nvidia (NASDAQ:NVDA) CEO Jensen Huang revealed that the company’s once-dominant market share in China has effectively evaporated, falling from over 90% to zero.

Twist Bioscience (NASDAQ:TWST) reported financial results for its second fiscal quarter ended March 31, 2026, showcasing sustained double-digit growth across its core synthetic biology and NGS platforms.

SAP (NYSE:SAP) today announced a definitive agreement to acquire Dremio, a leader in data lakehouse technology, in a move designed to collapse the silos between SAP and non-SAP data environments.

Helix Energy Solutions Group (NYSE:HLX) announced the divestiture of its Gulf of America-focused Shallow Water Abandonment business to C-Dive, a member of the Chouest group of companies.

Compass Diversified (NYSE:CODI), an owner of middle-market businesses, announced the successful completion of the sale of Sterno’s foodservice operations to Archer Foodservice Partners.

Krystal Biotech (NASDAQ:KRYS) reported robust financial results for the first quarter of 2026, highlighted by continued commercial momentum for VYJUVEK, the first and only redosable gene therapy for dystrophic epidermolysis bullosa.

Pinnacle West Capital (NYSE:PNW) reported a significant financial turnaround for the first quarter of 2026, posting consolidated net income of $32.9 million, or $0.27 per diluted share.